N,N-Dimethyltryptamine (DMT) undergoes a major structural alteration when added to whole human blood or its red blood cells in vitro. A new high-pressure liquid chromatography (HPLC) peak is present in extracts of these treated tissues. The compound responsible for this peak has been identified by ultraviolet spectrophotometry and by mass spectrometry as dimethylkynuramine (DMK). The enzyme responsible for this appears to be different from tryptophan 2,3-dioxygenase and also from indoleamine 2,3-dioxygenase.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0006-3223(86)90010-7 | DOI Listing |
Publication Analysis
Top Keywords
metabolic pathway
4
pathway nn-dimethyltryptamine
4
nn-dimethyltryptamine nn-dimethyltryptamine
4
nn-dimethyltryptamine dmt
4
dmt undergoes
4
undergoes major
4
major structural
4
structural alteration
4
alteration human
4
human blood
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!